CP and infection: Carbapenemase-producing CRE (CP-CRE) are of clinical and public health concern because carbapenem resistance is transmissible between organisms and patients, these organisms have limited treatment options, there is no decolonization strategy, and infections with these organisms are associated with high mortality rates (2).